118 related articles for article (PubMed ID: 6750247)
1. Prostacyclin in cardiopulmonary bypass operations.
Faichney A; Davidson KG; Wheatley DJ; Davidson JF; Walker ID
J Thorac Cardiovasc Surg; 1982 Oct; 84(4):601-8. PubMed ID: 6750247
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
Rådegran K; Arén C; Teger-Nilsson AC
J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
[TBL] [Abstract][Full Text] [Related]
3. A double blind study of prostacyclin in cardiopulmonary bypass surgery.
Walker ID; Davidson JF; Faichney A; Wheatley DJ; Davidson KG
Br J Haematol; 1981 Nov; 49(3):415-23. PubMed ID: 6457624
[TBL] [Abstract][Full Text] [Related]
4. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.
Malpass TW; Amory DW; Harker LA; Ivey TD; Williams DB
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):550-5. PubMed ID: 6231433
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
[TBL] [Abstract][Full Text] [Related]
6. Experience with prostacyclin in cardiopulmonary bypass in dog and man.
Longmore DB
Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):399-412. PubMed ID: 6117901
[TBL] [Abstract][Full Text] [Related]
7. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children.
Seear MD; Wadsworth LD; Rogers PC; Sheps S; Ashmore PG
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):217-9. PubMed ID: 2666759
[TBL] [Abstract][Full Text] [Related]
8. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
[TBL] [Abstract][Full Text] [Related]
9. [Effects of prostacyclin (PGI2) on tachycardic heart arrhythmias following aortocoronary venous bypass operations].
Heinrich D; Wagner WL; Höge R
Herz; 1985 Dec; 10(6):357-65. PubMed ID: 3936760
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
11. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
12. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
13. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin administration during cardiopulmonary bypass in man.
Longmore DB; Bennett JG; Hoyle PM; Smith MA; Gregory A; Osivand T; Jones WA
Lancet; 1981 Apr; 1(8224):800-4. PubMed ID: 6111672
[TBL] [Abstract][Full Text] [Related]
15. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study.
Vander Salm TJ; Ansell JE; Okike ON; Marsicano TH; Lew R; Stephenson WP; Rooney K
J Thorac Cardiovasc Surg; 1988 Mar; 95(3):538-40. PubMed ID: 3278170
[TBL] [Abstract][Full Text] [Related]
16. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery.
Koskenkari J; Rimpiläinen J; Biancari F; Surcel HM; Kaukoranta P; Kiviluoma K; Ala-Kokko T; Juvonen T
Scand Cardiovasc J; 2005 Dec; 39(6):358-68. PubMed ID: 16352489
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
[TBL] [Abstract][Full Text] [Related]
20. Hypotension induced by prostacyclin treatment during cardiopulmonary bypass does not increase the risk of cerebral complications.
Arén C; Blomstrand C; Wikkelsö C; Rådegran K
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):748-53. PubMed ID: 6208432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
